Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Neuroblastoma cells contain a trophic factor sharing biological and molecular properties with ciliary neurotrophic factorJ Heymanns, K UnsickerLeukemia & Lymphoma|December 29, 1999
Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenström's macroglobulinaemiaR Weide, J Heymanns, H KöpplerOnkologie|July 17, 2001
Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactionsH Köppler, J Heymanns, R WeideJournal of Cancer Research and Clinical Oncology|January 1, 1989
Tetanus toxin as a marker for small-cell lung cancer cell linesJ Heymanns, K Neumann, K HavemannBritish Journal of Haematology|August 6, 2000
The polyneuropathy associated with Waldenström's macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximabR Weide, J Heymanns, H KöpplerAgents and Actions|April 1, 1982
Comparative studies of mast cells from normal (non-immunized) and actively sensitized dogsJ Heymanns, H Behrendt, W SchmutzlerLupus|November 5, 2003
Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapyR Weide, J Heymanns, A Pandorf, et al.MMW Fortschritte Der Medizin|July 9, 2005
[Lymphomas: new therapeutic options]R Weide, J Heymanns, J Thomalla, et al.Arthritis and Rheumatism|May 1, 1990
A randomized controlled trial of ciamexon versus placebo in the immunomodulatory treatment of rheumatoid arthritisC Baerwald, K M Goebel, A Krause, et al.Clinical and Experimental Immunology|January 1, 1991
Imbalance of CD4+CD45R+ and CD4+CD29+ T helper cell subsets in patients with atopic diseasesU Schauer, T Jung, J Heymanns, et al.Pageof 4